Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Beijing Minhai 13-valent pneumococcal conjugate vaccine persistence and long-term safety in children
CTR20233343Phase 4Completed
- Sponsor
- Beijing Minhai Biological
- Start
- Oct 2023
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of pneumococcal 13-valent conjugate vaccine in pneumococcal disease, sponsored by Beijing Minhai Biological. Started Oct 2023; status: completed.
02
Drugs
pneumococcal 13-valent conjugate vaccine
03
Conditions
pneumococcal disease
Beyond the preview
Go deeper on CTR20233343.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20233343.